| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-07 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |